Innate Immunotherapeutics Limited

In the vibrant heart of Auckland, where innovation meets passion, stands Innate Immunotherapeutics Limited - a pioneering force in the realm of pharmaceuticals. Since our inception, we've been committed to pushing the boundaries of biopharmaceutical development, with a relentless focus on modifying the immune response to tackle some of humanity's most formidable foes: infectious diseases, cancer, and fibrotic conditions. Our journey began decades ago, with the pursuit of a solution for multiple sclerosis, culminating in MIS416 - a testament to our unwavering dedication to making a tangible difference in people's lives. Today, we continue this quest under a new banner - Amplia Therapeutics. Our current focus is on the development of a Focal Adhesion Kinase (FAK) inhibitor and fibrotic disease treatments, aiming to bring about groundbreaking advancements in healthcare. We are not just a pharmaceutical company; we are a community of scientists, researchers, and visionaries, bound together by a shared dream. We work tirelessly, driven by the knowledge that every breakthrough brings us one step closer to a healthier world. Our lab is filled with the hum of ideas, the click-clack of keyboards, and the whirr of machines - all in pursuit of the next medical miracle. Innate Immunotherapeutics Limited isn't just about drugs and treatments; it's about hope, resilience, and the relentless human spirit. It's about the promise that tomorrow can always be better than today. So, whether you're a patient seeking solace in our quest for a cure or a professional inspired by our unyielding commitment to innovation, we invite you to join us on this incredible journey. Together, we will write the next chapter in the story of human health.